Results 211 to 220 of about 104,745 (290)
CldU sensitizes <i>BRCA2</i> reverse-mutated cells to PARP inhibitors. [PDF]
Zouggari N +6 more
europepmc +1 more source
Tumour Suppressor Mechanisms in the Control of Chromosome Stability: Insights from BRCA2
Ashok R. Venkitaraman
openalex +2 more sources
Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of <i>BRCA1</i> or <i>BRCA2</i> Pathogenic Variants. [PDF]
Abdel-Razeq H, Mansour R.
europepmc +1 more source
Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients [PDF]
Elisabeth Jarhelle +7 more
openalex +1 more source
The expanding roles of homologous recombination proteins in genome stability. [PDF]
Sassi L +4 more
europepmc +1 more source
Germline <i>BRCA1/2</i> Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. [PDF]
Skoczylas S +8 more
europepmc +1 more source

